CPT code 52327 denotes cystourethroscopy with subureteral injection of implant material to correct vesicoureteral reflux. This endoscopic urologic procedure inspects the bladder and urethra and delivers an implant beneath the ureteral orifice to reduce retrograde urine flow. Nationally, the code matters for pediatric and adult urology practices that manage reflux non-surgically and for payers that define coverage and site-of-service distinctions for minimally invasive therapies.

Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for use of the code, typical settings of care (ambulatory surgery centers and hospital outpatient departments), common billing modifiers that may apply, and areas where policy and coverage language can affect claims processing and site-of-service selection. The publication highlights benchmarking topics such as utilization patterns, reimbursement considerations, and coding accuracy priorities that influence payment and compliance. Practical guidance is limited to informational context; specific coverage determinations should be confirmed with individual payers.